Nestle Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or the special challenges of different life stages.
With this acquisition, Nestle Health Science expects to enhance its nutritional solutions to deliver improved personalized healthcare for medical conditions.
Prometheus president and CEO Joseph Limber said with Nestle Health Science’s support, they will accelerate the development of their diagnostic platforms for gastroenterology and oncology and potentially into additional important therapeutic areas.
"We also intend to leverage Nestle Health Science’s nutritional product offerings and geographic presence to expand our successful Rx/Dx business model into a Dx/Nx/Rx model," Limber said.